Single Tertiary Care Center Outcomes After Lower Extremity Cadaveric Vein Bypass for Limb Salvage

Abstract

Objective:

Cadaveric saphenous vein (CV) conduits are used in rare instances for limb salvage in patients without autogenous veins although long-term outcome data are scarce. This study was designed to evaluate the outcomes of CV bypass in patients with threatened limbs.

Methods:

We retrospectively reviewed the charts from 2010 to 2017 of 25 patients who underwent 30 CV allografts for critical limb ischemia and acute limb ischemia. Patient charts were reviewed for demographics, comorbidities, smoking status, indications for bypass, and outcomes. Primary outcomes included graft patency, major amputation rates, and mortality. Secondary outcomes measured included infection rates, 30-day major adverse cardiac events (MACE) and major adverse limb events (MALE). Statistical analysis was performed using time series and Kaplan-Meier survival curves.

Results:

A total of 30 limbs received CV lower extremity bypasses (20 males, 10 female), and the average age was 68 ± 4 years. Primary patency rates were 71%, 42%, and 28% at 3, 6, and 12 months, respectively. Assisted primary patency rates were 78%, 56%, and 37% at 3, 6, and 12 months, respectively. Secondary patency rates were 77%, 59%, and 28% at 3, 6, and 12 months, respectively. Minor amputations, defined as amputations below the transmetatarsal level occurred in 5 (20%) patients. Wound infection occurred in 8 (32%) patients which was managed with local wound care and no patients required an extraanatomic bypass for limb salvage. Thirty-day MALE occurred in 7 (23.3%) patients. We had no 30-day mortality or MACE. The average graft length was 64.2 ± 8 cm with an average graft diameter of 3.9 ± 2 mm. Amputation-free survival and overall survival at 12 months were 20 (68%) and 21 (84%), respectively.

Conclusions:

Cadaveric saphenous vein allograft may be used as a bypass conduit as a viable surgical option before limb amputation. Despite the poor patency rates, the limb salvage rates of cadaveric vein grafts demonstrate that this alternate conduit may be considered when no autogenous vein is available.

Keywords

cadaveric vein bypass saphenous vein limb salvage

Get full access to this article

View all access options for this article.

References

Chang

Scali

Feezor

, et al. Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia. J Vasc Surg. 2014;60(6):1554–1564. doi:10.1016/j.jvs.2014.06.009

Randon

Jacobs

De Ryck

Beele

Vermassen

. Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vasc Surg. 2010;51(4):869–877. doi:10.1016/j.jvs.2009.11.062

Norgren

Hiatt

Dormandy

Nehler

Harris

Fowkes

FGR

. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(1): S5–S67. doi:10.1016/j.jvs.2006.12.037

Hartranft

Noland

Kulwicki

Holden

Hartranft

. Cryopreserved saphenous vein graft in infrainguinal bypass. J Vasc Surg. 2014;60(5):1291–1296. doi:10.1016/j.jvs.2014.05.092

Posner

Makhoul

Altman

, et al. Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression. J Am Coll Surg. 1996;183(3):208–216.

Pulli

Dorigo

Castelli

, et al. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg. 2010;51(5):1167–1177.e1. doi:10.1016/j.jvs.2009.12.042

Dorigo

Pulli

Castelli

, et al. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics. J Vasc Surg. 2011;54(5):1332–1338. doi:10.1016/j.jvs.2011.05.046

Neville

Capone

Amdur

Lidsky

Babrowicz

Sidawy

. A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia. J Vasc Surg. 2012;56(4):1008–1014. doi:10.1016/j.jvs.2012.03.020

Kaisar

Chen

Cheung

Kfoury

Bechara

Lin

. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass. Vascular. 2018;26(2):117–125. doi:10.1177/1708538117717141

10.

Buckley

Abernathy

Lee

Arko

Patterson

Manning

. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts. J Vasc Surg. 2000;32(4):731–738. doi:10.1067/mva.2000.110049

11.

O’Banion

Eichler

Reilly

Conte

Hiramoto

. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage. J Vasc Surg. 2017;66(3):844–849. doi:10.1016/j.jvs.2017.03.415

12.

Faries

Arora

Pomposelli

, et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg. 2000;31(1):50–59. doi:10.1016/S0741-5214(00)70067-X

13.

Harward

TRS

Coe

Flyrm

Seeger

. The use of arm vein conduits during infrageniculate arterial bypass. J Vasc Surg. 1992;16(3):8.

14.

Harris

O’brien-Irr

Ricotta

. Long-term assessment of cryopreserved vein bypass grafting success. J Vasc Surg. 2001;33(3):528–532. doi:10.1067/mva.2001.111729

15.

Johnson

Glickman

Bandyk

Esses

. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg. 1995;22(3):280–285; discussion 285-286.

16.

Fujitani

Bassiouny

Gewertz

Glagov

Zarins

. Cryopreserved saphenous vein allogenic homografts: an alternative conduit in lower extremity arterial reconstruction in infected fields. J Vasc Surg. 1992;15(3):8.

17.

Dietzek

Gupta

Kram

Wengerter

Veith

. Limb loss with patent infra-inguinal bypasses. Eur J Vasc Endovasc Surg. 1990;4(4):413–417. doi:10.1016/S0950-821X(05)80877 -1

18.

Simons

Goodney

Nolan

, et al. Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg. 2010;51(6):1419–1424. doi:10.1016/j.jvs.2010.01.083

19.

Albers

Romiti

Brochado-Neto

De Luccia

Pereira

CAB

. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006;43(3):498–503. doi:10.1016/j.jvs.2005.11.025